BSEBoard Meeting31 Oct 2026 · 31 Oct 2026, 07:03 pm

Cresanto Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. Un-audited Financial Results of the Company for the Second quarter ended 30th September, 2026. 2. To note and take on record the Limited Review Report for the Second quarter ended 30th September, 2026. 3. To consider any other business with the permission of the Chair.

Cresanto Global Ltd · 531207

✦ AI SummaryResults

Cresanto Global Ltd has scheduled a Board Meeting on 05/11/2026 to consider and approve un-audited financial results for the second quarter ended 30/09/2026, and to note the limited review report for the same period.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cresanto Global Ltd - 531207 - Board Meeting Intimation for Approval Of Q2 Financial Result For 2026-27.

Attachments (1)

📄

3f6afce8-921b-43cb-9650-54c22f0d842d.pdf

pdf

Download →
View document text
CP.LSA“!TQ | CRESANTO GLOBAL LIMITED THE POWER BEHIND (Formerly kiown as Raymed Labs Limited) Reg.off: C- 273, C block, Sector 63, Gautam Buddha Nagar, Noida,Uttar Pradesh-201301 CIN:L22203UP1992PLC014240 Website: www.cresantoglobal.com Email: paymedlabs@rediffmail.com. Phone no. 7738669898 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip code- 531207 Subject: Intimation of Board Meeting Ref: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, In term of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby intimated that the Meeting of Board of Directors of the Company is scheduled to be held on Thursday, 05*" November, 2026 at the corporate office of the company to inter alia consider and approve: 1. Un-audited Financial Results of the Company for the second quarter ended 30" September, 2026. 2. To note and take on record the Limited Review Report for the second quarter ended 30" September, 2026. 3. To consider any other business with the permission of the Chair. Further, in terms of the Prohibition of Insider Trading Code adopted by the Company the Window Closure for Trading by Designated Persons of the Company shall remain close from Thursday, 01% October, 2026 till Saturday, 07" November, 2026, i.e. 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended 30t September, 2026. Thanking you, For Cresanto Global Limited (Formerly known as Raymed Labs Limited) (Prashant Nathmal Bajaj) Managing Director DIN: 06634046 Date: 31° October, 2026 Place: Mumbai